Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C

• मुख्य लेखकों: P. Marrero-Álvarez (लेखक), I. Gil-Gómez (लेखक), E. Monte-Boquet (लेखक), L. Lorente-Fernández (लेखक), J. L. Poveda-Andrés (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2014-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract: Introduction: Protease inhibitors, boceprevir and telaprevir, have changed the treatment paradigm of chronic hepatitis C (CHC). The objective is analyzing the degree of compliance with the recommendations for boceprevir and telaprevir use that have been issued for the Spanish Agency for Me...